BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36581740)

  • 1. Outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing robotic (RPD) or open pancreaticoduodenectomies (OPD): a propensity score-weighted survival analysis.
    Mejia A; Shah J; Vivian E; Beard R; Acharya P; Gutierrez JCB
    J Robot Surg; 2023 Jun; 17(3):1085-1096. PubMed ID: 36581740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robotic versus open pancreatoduodenectomy in patients with pancreatic duct adenocarcinoma after the learning curve: a propensity score-matched analysis.
    Chen H; Weng Y; Zhao S; Wang W; Ji Y; Peng C; Deng X; Shen B
    Surg Endosc; 2024 Feb; 38(2):821-829. PubMed ID: 38066192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
    Weng Y; Jiang Y; Fu N; Jin J; Shi Y; Huo Z; Deng X; Peng C; Shen B
    Surg Endosc; 2021 Jul; 35(7):3437-3448. PubMed ID: 32696148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates: A Multicenter Propensity Score-Matched Study.
    Liu Q; Zhao Z; Zhang X; Wang W; Han B; Chen X; Tan X; Xu S; Zhao G; Gao Y; Gan Q; Yuan J; Ma Y; Dong Y; Liu Z; Wang H; Fan F; Liu J; Lau WY; Liu R
    Ann Surg; 2023 Apr; 277(4):e864-e871. PubMed ID: 34417366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robotic approach mitigates the effect of major complications on survival after pancreaticoduodenectomy for periampullary cancer.
    Meyyappan T; Wilson GC; Zeh HJ; Hogg ME; Lee KK; Zureikat AH; Paniccia A
    Surg Endosc; 2023 Feb; 37(2):1181-1187. PubMed ID: 36163566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robotic versus open pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma: surgical and oncological outcomes from pilot experience.
    Jin J; Yin SM; Weng Y; Chen M; Shi Y; Ying X; Gemenetzis G; Qin K; Zhang J; Deng X; Peng C; Shen B
    Langenbecks Arch Surg; 2022 Jun; 407(4):1489-1497. PubMed ID: 35088144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Propensity Score-Matched Analysis of Robotic vs Open Pancreatoduodenectomy on Incidence of Pancreatic Fistula.
    McMillan MT; Zureikat AH; Hogg ME; Kowalsky SJ; Zeh HJ; Sprys MH; Vollmer CM
    JAMA Surg; 2017 Apr; 152(4):327-335. PubMed ID: 28030724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robotic versus open pancreaticoduodenectomy for distal cholangiocarcinoma: a multicenter propensity score-matched study.
    Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Hu MG; Gao YX; Tan XL; Liu Q; Liu R
    Surg Endosc; 2022 Nov; 36(11):8237-8248. PubMed ID: 35534733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy.
    Zureikat AH; Postlewait LM; Liu Y; Gillespie TW; Weber SM; Abbott DE; Ahmad SA; Maithel SK; Hogg ME; Zenati M; Cho CS; Salem A; Xia B; Steve J; Nguyen TK; Keshava HB; Chalikonda S; Walsh RM; Talamonti MS; Stocker SJ; Bentrem DJ; Lumpkin S; Kim HJ; Zeh HJ; Kooby DA
    Ann Surg; 2016 Oct; 264(4):640-9. PubMed ID: 27433907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pancreatic cancer.
    Nassour I; Tohme S; Hoehn R; Adam MA; Zureikat AH; Alessandro P
    Surg Endosc; 2021 May; 35(5):2248-2254. PubMed ID: 32440928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A propensity score-matched analysis of robotic versus open pancreatoduodenectomy for pancreatic cancer based on margin status.
    Kauffmann EF; Napoli N; Menonna F; Iacopi S; Lombardo C; Bernardini J; Amorese G; Cacciato Insilla A; Funel N; Campani D; Cappelli C; Caramella D; Boggi U
    Surg Endosc; 2019 Jan; 33(1):234-242. PubMed ID: 29943061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of robotic and open pancreaticoduodenectomy for primary nonampullary duodenal adenocarcinoma: a retrospective cohort study.
    Wang W; Liu Q; Zhao ZM; Tan XL; Wang ZZ; Zhang KD; Liu R
    Langenbecks Arch Surg; 2022 Feb; 407(1):167-173. PubMed ID: 34471952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity score-matched comparison of the oncological feasibility and survival outcomes for pancreatic adenocarcinoma with robotic and open pancreatoduodenectomy.
    Shyr BU; Shyr BS; Chen SC; Shyr YM; Wang SE
    Surg Endosc; 2022 Feb; 36(2):1507-1514. PubMed ID: 33770276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching.
    Vining CC; Kuchta K; Schuitevoerder D; Paterakos P; Berger Y; Roggin KK; Talamonti MS; Hogg ME
    J Surg Oncol; 2020 Aug; 122(2):183-194. PubMed ID: 32445612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
    Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
    Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robotic pancreaticoduodenectomy may offer improved oncologic outcomes over open surgery: a propensity-matched single-institution study.
    Baimas-George M; Watson M; Murphy KJ; Iannitti D; Baker E; Ocuin L; Vrochides D; Martinie JB
    Surg Endosc; 2020 Aug; 34(8):3644-3649. PubMed ID: 32328825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study.
    Naffouje SA; Kamarajah SK; Denbo JW; Salti GI; Dahdaleh FS
    Ann Surg Oncol; 2022 Nov; 29(12):7793-7803. PubMed ID: 35960450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer?
    Stefanova I; Vescio F; Nickel F; Merali N; Ammendola M; Lahiri RP; Pencavel TD; Worthington TR; Frampton AE
    Expert Rev Gastroenterol Hepatol; 2024; 18(4-5):133-139. PubMed ID: 38712525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
    Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
    BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of laparoscopic versus open pancreaticoduodenectomy in patients with resectable pancreatic ductal adenocarcinoma: A propensity score-matching analysis of long-term survival.
    Zhang Z; Yin T; Qin T; Pan S; Wang M; Zhang H; Qin R
    Pancreatology; 2022 Mar; 22(2):317-324. PubMed ID: 34969601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.